PeptideStack
5.2kquestions
20kanswers
220users

If I reconstitute a 15 mg vial with 5 mL of phosphate-buffered diluent, what concentration do I end up with?

Asked 26 May 2026Modified 12 days agoViewed 6.9k times
13

For reference: 15 mg · 5 mL · phosphate-buffered diluent.

I would like the arithmetic checked rather than the conclusion asserted.

I have deliberately not used an online calculator because I want to be able to check the result.

What is the general form of this calculation?

reconstitution
reconstitution

Taking a lyophilised vial to a solution of known concentration: choice of diluent, volume selection, how to add liquid without shearing the cake,…

330 questions
diluent-volume
diluent-volume

Choosing how much diluent to add, which is really a question about what you want your measurement resolution to be. Larger volumes buy you…

308 questions
dosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

811 questions
shareeditfollowflag
CD
askedcolm_dunphy16k1626 May 2026

5 Answers

Accepted answer first, then by votes
11

Accepted answer

Add the diluent down the vial wall rather than directly onto the cake. Peptides are surface-active and shear at an air–liquid interface, so a jet of water into a lyophilised puck generates foam, and foam is aggregated protein at the interface, not just air.

Photograph the vial against a matte black card with a single point light source off to one side, not with a flash from the front.

Room temperature before drawing is worth the ten minutes. Cold solution is more viscous, draws slower, and is more likely to pull a bubble past the plunger seal.

Published data on syringe dead space in the context of injection-equipment programmes quantifies low-dead-space designs as retaining under 2 µL against 35 µL or more.

The caveat is that this is not a recommendation to administer anything. Research-use-only material is not approved for human use.

The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing, and check the syringe scale.

shareimprove this answerflag
P9
answered · acceptedplate_count_9k95k15815 Jun 2026
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
11

The distinction that resolves most of these questions is that bacteriostatic water suppresses microbial growth and does not sterilise anything. It buys you a multiple-withdrawal presentation; it does not make an unsterile preparation sterile, and it does not substitute for technique.

Tilting the vial to pool solution in the corner before the final draw, and giving it a minute to drain down the walls, genuinely recovers ten to twenty microlitres.

A 0.22 µm syringe filter will remove particulates and organisms, and it will also adsorb a fraction of your peptide.

Coring of elastomeric closures is a well-characterised failure mode in the parenteral packaging literature.

I would flag the obvious failure mode: people get the concentration right, get the volume right, and then read the syringe against the wrong scale.

None of this is exotic. It is just the difference between doing it deliberately and doing it approximately.

shareimprove this answerflag
SG
answeredsinead_gaffney14k2817 Jul 2026
Related: the same reasoning applies to the counter-ion question. – ahmed_zerouali 4 months ago
add a comment
8

If the supplier documentation specifies a diluent, there is usually a reason, and if it specifies nothing, water for injection is the conservative default.

Write the arithmetic on the vial label. It costs nothing and removes the step where you reconstruct it from memory at an inconvenient moment.

On the detail: number of stopper piercings matters less than the gauge doing the piercing.

The general principle — that peptides adsorb and denature at air–liquid and solid–liquid interfaces — is standard formulation science.

The caveat on all of this is that it assumes the vial contains what the label says.

Do the arithmetic twice, ideally with someone else doing it independently.

shareimprove this answerflag
IB
answeredines_brandt93k2481 Jul 2026
Two of us worked through this independently and arrived here, so it is at least reproducible. – bounty_hunter_q 6 months ago
Worth adding that the method section is where the answer usually is. – stopper_core 4 months ago
add a comment
5

The relevant detail is that the dissolution time is a signal — if it is longer than expected, something went wrong in either the lyophilisation or the shipping.

The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing.

The 28-day beyond-use convention for a multiple-withdrawal preserved preparation derives from USP compounding chapters, which set it on microbiological risk rather than chemical stability.

The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing, and check the syringe scale.

shareimprove this answerflag
AN
answeredamara_nwachukwu41k3818 Jul 2026
4

Specifically, read the cake before you touch the vial. An intact, opaque, evenly distributed puck that sits proud of the vial base is what a good lyophilisation cycle produces. Anything else — collapse, melt-back at the stopper, a glassy film, a cake that has slumped to one side — is evidence about the cycle, the shipping, or both.

Check the barrel marking, not your memory of it.

One limitation: technique reduces risk, it does not remove it.

None of this is exotic. It is just the difference between doing it deliberately and doing it approximately.

edited 30 May 2026 by Dr_Otto_Lindqvist — added the citation requested in comments

shareimprove this answerflag
DL
answeredDr_Otto_Lindqvist38k3830 May 2026

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.